PCVX
PCVX
NASDAQ · Biotechnology

Vaxcyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$51.96
-0.15 (-0.29%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +29.1% upside
Low Target $56.09
Average Target $67.08
High Target $108.72
Current Price $51.96
Current
$51.96
Target
$67.08
$56.09 $67.08 avg $108.72
Scenario Analysis
Bear Case
$56.09
7.9%
Low target
Base Case
$67.08
+29.1%
Avg target
Bull Case
$108.72
+109.2%
High target
Risk/Reward
13.7x
Highly favorable
Price in Context
52-Week High
$65.00
-20.1% from high
52-Week Low
$29.08
+78.7% from low
50-Day SMA
$49.46
+5.1% vs SMA
200-Day SMA
$39.88
+30.3% vs SMA
RSI (14)
62.6
Neutral
Target vs 52W High
$67.08
+3.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%